$GEMZ News: GEMXX Corporation Forecasts Soaring Growth in

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams trooperstocks #40219
66
$GEMZ News: GEMXX Corporation Forecasts Soaring Growth in India’s Colored Gemstones and Gold Markets

LAS VEGAS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- via IBN -- GEMXX Corporation ( OTC: GEMZ ) ("GEMXX" or the "Company" , a leading provider of exquisite gemstone jewelry, is excited to announce its insights into the burgeoning jewelry market in India, showcasing remarkable growth projections between 2023 and 2033.

According to recent industry forecasts, the jewelry market in India is poised for exceptional expansion, with an estimated increase of USD 21.54 billion anticipated between 2023 and 2027. This surge is supported by an impressive compound annual growth rate (CAGR) of 5.54%, positioning India as a key player in the global jewelry arena.

In specific focus, the colored gemstones market in India is expected to reach US$ 707.8 million in 2024, with a robust 10.5% CAGR projected between 2023 and 2033. This acceleration is anticipated to culminate in a staggering US$ 1.9 billion for the market by 2033.

“This industry forecast pinpointing the increase in demand for colored gemstones and gold allows investors a safe haven for investing in a company backed by gemstones and gold rather than a sometimes-volatile technology stock,” stated Jay Maull, CEO of GEMXX Corp.

"The growth rate of the colored gemstone market in India is surpassing the overall growth rate of the jewelry market in India by 2.1%. Ammolite, a relatively recent addition to the Indian colored gemstone market, has the potential to attract a significant portion of buyers seeking something innovative or distinct from conventional colored gemstones," further commented Jay Maull, CEO of GEMXX Corp.

Beyond mere aesthetics, gemstones and gold in India hold a distinct significance for a substantial portion of the population, believed to possess divine powers. The demand for colored gemstones is also on the rise, driven by their perceived Vedic properties, making them more than just precious stones but also carriers of sentimental and astrological value.

GEMXX Corporation is strategically positioned to capitalize on this growing trend, offering an extensive range of ammolite products to cater to the evolving preferences of the Indian market. As a global leader in the industry, GEMXX Corp continues to innovate and provide unique gemstone options that resonate with the cultural and spiritual sentiments of consumers.

ABOUT GEMXX CORPORATION
GEMXX Corporation (OTC: GEMZ; $GEMZ) is a publicly traded, mine-to-market gold, gemstone and jewelry producer with global reach that owns mining resources, production facilities and operating assets. GEMXX controls each stage of its production including gold mining, gemstone production, jewelry manufacturing and global distribution.

GEMXX is a leading producer of top-quality finished ammolite and ammolite jewelry. The Company’s world-class gemstone cutters and jewelry designers are continuously leading the ammolite industry in new and exciting directions. Our management team is made up of the industry's leading experts with a combined total of 160 years of ammolite gemstone and jewelry business experience.

For more information, please visit: GEMXX Corporation

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our Company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Signed. /S/ Jay Maull, CEO
GEMXX Corporation

For more information, please contact:

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

https://www.globenewswire.com/newsroom/ti?nf=...ExNzcxNw==
https://ml.globenewswire.com/media/Yzc1ZTRhYj...ration.png

Source: GEMXX Corporation
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading